Psychotropic medication use in Swiss nursing homes | Zendy

I Lustenberger | Zendy; B Schüpbach | Zendy; Armin von Gunten | Zendy; Urs P. Mosimann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Psychotropic medication use in Swiss nursing homes

Author(s) -

I Lustenberger,

B Schüpbach,

Armin von Gunten,

Urs P. Mosimann

Publication year - 2011

Publication title -

schweizerische medizinische wochenschrift

Language(s) - English

Resource type - Journals

ISSN - 0036-7672

DOI - 10.4414/smw.2011.13254

Subject(s) - medicine , nursing homes , nursing , family medicine , psychiatry , intensive care medicine

Psychotropic medication is commonly used in nursing homes, to treat behavioural and psychological symptoms of dementia (BPSD) for example. Treatment with antipsychotics may improve BPSD in some residents but can be associated with serious side effects, such as higher mortality, faster disease progression and cerebrovascular events. In the current study, psychotropic medication use was analysed in a representative sample of nursing home residents in the German-speaking part of Switzerland, at entry and during follow-up

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research